Building Physician Capacity for HPV Vaccine Uptake in India: Mixed-Methods Implementation Outcomes of a Train-the-Trainer Model Using RE-AIM
Authors:
- Ashleigh FlowersAFAshleigh Flowers
- Shaylen FoleySFShaylen Foley
- Swati SaxenaSSSwati Saxena
- Sutapa BiswasSBSutapa Biswas
- Priya GaneshkumarPGPriya Ganeshkumar
- Purna KurkurePurna Kurkure
- Upendra KinjawadekarUKUpendra Kinjawadekar
- Sara ComstockSCSara Comstock
- Nina DaSilva BatistaNBNina DaSilva Batista
- Meenu AnandMAMeenu Anand
Open Access
Abstract
Background: India accounts for one-fifth of global cervical cancer deaths, yet Human Papillomavirus (HPV) vaccination coverage remains low despite the World Health Organization (WHO) recommendations to initiate vaccination at age 9. With the national HPV vaccination campaign in 2026 and its approval for integration into India’s Universal Immunization Programme (UIP), strengthening physician knowledge, beliefs, and confidence in recommending the vaccine is critical. Methods: In 2023, the American Cancer Society and Cancer Foundation of India catalyzed two national medical societies, the Federation of Obstetric and Gynaecological Societies of India and the Indian Academy of Pediatrics, to educate physicians on HPV vaccination using a train-the-trainer (ToT) model. A mixed-methods evaluation, using the RE-AIM Framework, included pre- and post-training surveys assessing changes in knowledge, beliefs, confidence, and intent, as well as monthly engagement surveys and project reports analyzed using descriptive and inferential statistics. A fidelity assessment evaluated consistency of training delivery. Twenty in-depth interviews explored physician reactions and implementation of learnings, analyzed using a rapid approach. Results: A total of 18,206 physicians were trained. The post-training respondent group demonstrated higher HPV vaccination knowledge scores and more favorable responses in confidence, beliefs, and intent than the pre-training respondent group. The fidelity assessment demonstrated consistent delivery overall, with some variability in role play facilitation. Interviews highlighted increased physician confidence, peer knowledge sharing, and community engagement following the training. Medical societies reported strong program adoption and plans for continued efforts. Conclusions: A ToT physician training cascaded through medical societies is a feasible strategy to prepare physicians to recommend the HPV vaccine and address parental concerns at scale.Keywords
Funding Information
- Cancer Research UK (66243)
- Greif, Inc.
- Merck (APA-21-147717)
- Merck Sharp & Dohme
This publication has 42 references indexed in Scilit:
- Cervical cancer burden in India: A descriptive epidemiological study and policy insightsGlobal Epidemiology, 2025
- HPV vaccine introduction in Pakistan: a strategic opportunity for multisectoral allianceThe Lancet Regional Health - Southeast Asia, 2025
- Awareness, perceptions, and choices of physicians pertaining to human papillomavirus (HPV) vaccination in India: A formative research studyVaccine: X, 2022
- What Works to Increase Vaccination UptakeAcademic Pediatrics, 2021
- Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016Papillomavirus Research, 2017
- Cost‐effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization programCancer, 2017
- Vaccine hesitancy and healthcare providersVaccine, 2016
- Knowledge and Attitudes Towards Human Papillomavirus (HPV) Among Academic and Community Physicians in Mangalore, IndiaJournal of Cancer Education, 2016
- Provider communication and HPV vaccination: The impact of recommendation qualityVaccine, 2016
- Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospectsVaccine, 2013